Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AMD3100 for Thin Endometrium in Infertility
NCT04045821Terminated
- Sponsor
- Reproductive Medicine Associates of New Jersey
- Start
- Jan 2020
- Primary completion
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of plerixafor in infertility (2 arms), sponsored by Reproductive Medicine Associates of New Jersey. Primary endpoint: Endometrial thickness. Started Jan 2020; status: terminated.
02
Drugs
plerixafor
03
Conditions
infertility
Beyond the preview
Go deeper on NCT04045821.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04045821.